Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Pfizer Inc. Patents
Assignee:
Pfizer Inc.
Address:
Madison, NJ
No. of patents:
3651
Patents:












Patent Number Title Of Patent Date Issued
RE41783 Pyrrolo[2,3-D]pyrimidine compounds September 28, 2010
A compound of the formula ##STR00001## wherein R.sup.1, R.sup.2 and R.sup.3 are as defined above, which are inhibitors of the enzyme protein kinases such as Janus Kinase 3 and as such are useful therapy as immunosuppressive agents for organ transplants, xeno transplation, lupus, mu
RE41065 Alkynl and azido-substituted 4-anilinoquinazolines December 29, 2009
The invention relates to compounds of the formula ##STR00001## and to pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, n and m are as defined herein. The compounds of formula I are useful in the treatment of hyperproliferative diseases, such as
RE40838 2-azabicyclo[3.3.1]nonane derivatives July 7, 2009
The subject invention relates to 2-azabicyclo[3.3.1]nonane derivatives, pharmaceutical compositions comprising such derivatives and methods of using such derivatives to treat disease states, disorders and conditions mediated by opioid receptors. The subject invention also particularly
RE39558 5-Substituted-6-cyclic-5,6,7,8-tetrahydronaphthalen 2-ol compounds which are useful for treating April 10, 2007
Compounds of this formula ##STR00001## are useful for treating or preventing, obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease.
RE39419 Estrogen agonist/antagonist metabolites December 5, 2006
This invention relates to compounds that are mammalian metabolites of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahyd- ro-naphthalene-2-ol. The compounds of the invention can be used as standards for analytical assays or as intermediates for the further chemi
RE39149 Method of administering azithromycin June 27, 2006
An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages c
RE38524 Dipeptide derivatives as growth hormone secretagogues June 1, 2004
This invention is directed to compounds of the formula ##STR1##and the pharmaceutically-acceptable salts thereof, where the substituents are as defined in the Specification, which are growth hormone secretogogues and which increase the level of endogenous growth hormone. The compound
RE35865 Preparation of glutaric acid derivatives July 28, 1998
The Invention provides a process for preparing a compound of the formula: ##STR1## or a base salt thereof, wherein R.sup.2 is hydrogen or C.sub.1 -C.sub.6 alkyl optionally substituted by up to 3 substituents each independently selected from the group consisting of C.sub.1 -C.sub.6 al
RE29669 Production of 4-hydroxy-1,2-benzothiazine-3-carboxamides June 13, 1978
A process for the synthesis of N-aryl-3,4-dihydro-2-alkyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides by treatment of N-aryl-N'-alkyl-N'-(2'-alkoxycarbonylbenzenesulfonyl)glycineamides, useful intermediates for said process, with an alkali or alkaline earth metal hydrid
RE29668 Glycineamides June 13, 1978
A process for the synthesis of N-aryl-3,4-dihydro-2-alkyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides by treatment of N-aryl-N'-alkyl-N'-(2'-alkoxycarbonylbenzenesulfonyl)glycineamides, useful intermediates for said process, with an alkali or alkaline earth metal hydrid
D670064 Structural arrangement for an in ovo injection device October 30, 2012
D499023 Liquid measuring vessel November 30, 2004
D450153 Applicator November 6, 2001
D444056 Blister package dispenser June 26, 2001
D440871 Blister package April 24, 2001
D437407 Pharmaceutical tablet February 6, 2001
D434136 Pharmaceutical tablet November 21, 2000
D434135 Pharmaceutical tablet November 21, 2000
D433750 Pharmaceutical tablet November 14, 2000
D433501 Pharmaceutical tablet November 7, 2000
D433500 Pharmaceutical tablet November 7, 2000
D433499 Pharmaceutical tablet November 7, 2000
D433122 Pharmaceutical tablet October 31, 2000
D433121 Pharmaceutical tablet October 31, 2000
D432714 Applicator October 24, 2000
D432641 Pharmaceutical tablet October 24, 2000
D431093 Applicator September 19, 2000
D430703 Applicator September 5, 2000
D415272 Pharmaceutical tablet October 12, 1999
D414552 Pharmaceutical tablet September 28, 1999
D414551 Pharmaceutical tablet September 28, 1999
D414259 Pharmaceutical tablet September 21, 1999
D413973 Pharmaceutical tablet September 14, 1999
D413972 Pharmaceutical tablet September 14, 1999
D410842 Bottle protecting container June 8, 1999
D400434 Combined liquid measuring vessel and bottle November 3, 1998
D392562 Blister pack March 24, 1998
D363430 Container having a curved back panel October 24, 1995
D353225 Nit comb December 6, 1994
D336540 Nit comb June 15, 1993
D311867 Cosmetic and perfume bottle November 6, 1990
D308428 Cosmetic case June 5, 1990
D286137 Combined pill dispenser and cover October 14, 1986
D273704 Orthopedic surgery brush May 1, 1984
D263172 Pharmaceutical tablet February 23, 1982
D251823 Folding garden tool May 15, 1979
D245316 Liquid dispenser August 9, 1977
8586721 Antibodies specific for DKK-1 and their uses November 19, 2013
The present invention provides antibodies and fragments thereof that bind to Dkk-1 and, in particular, to humanized antibodies and fragments thereof that bind to Dkk-1 and, even more particularly to fully humanized antibodies and immunologically functional fragments that bind to Dkk-1.
8562985 Antibodies to c-Met October 22, 2013
The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions
8293903 3-aminocyclopentanecarboxamides as chemokine receptor agonists October 23, 2012
There is provided a compound of Formula I(a) or I(b) ##STR00001## or a pharmaceutically acceptable salt thereof, wherein the various substituents are defined herein.

 
 
  Recently Added Patents
Charging current control method and charging system
Relative pose estimation of non-overlapping cameras using the motion of subjects in the camera fields of view
Antenna array system
Water slide
Methods of measuring cell viability in tissue engineered products
Inhibitors of bacterial nitric oxide synthase, and related screening methods
Color LED display device without color separation
  Randomly Featured Patents
Dispenser for dispensing pills or tablets in a predetermined order
Real-time Bayesian 3D pose tracking
Container
Display screen or portion thereof with graphical user interface
Apparatus for reproducing signal from multi-layered optical disk using multiple photo detectors
In-plane switching mode liquid crystal display device and method of manufacturing the same
Image forming apparatus having different modes for preventing defective cleaning
Exhaust gas purifying method and purifier
Tactile, audio and visual stimulation unit
Using signal to noise ratio of a speech signal to adjust thresholds for extracting speech parameters for coding the speech signal